BDSX
Biodesix Inc
NASDAQ: BDSX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.32
-0.97% today
Updated 2026-05-08
Market cap
$113.91M
P/E ratio
—
P/S ratio
1.29x
EPS (TTM)
$-4.75
Dividend yield
—
52W range
$3 – $20
Volume
0.1M
Biodesix Inc (BDSX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $20.43M | $24.55M | $45.56M | $54.51M | $38.21M | $49.09M | $71.32M | $88.50M |
| Revenue growth (YoY) | — | +20.2% | +85.6% | +19.6% | -29.9% | +28.5% | +45.3% | +24.1% |
| Cost of revenue | $4.41M | $6.07M | $22.00M | $30.52M | $14.15M | $13.01M | $15.57M | $21.91M |
| Gross profit | $16.03M | $18.48M | $23.56M | $23.99M | $24.06M | $36.08M | $55.75M | $66.59M |
| Gross margin | 78.4% | 75.3% | 51.7% | 44.0% | 63.0% | 73.5% | 78.2% | 75.2% |
| R&D | $8.19M | $10.47M | $10.82M | $12.79M | $13.10M | $9.99M | $9.56M | $12.00M |
| SG&A | $25.90M | $30.64M | $34.86M | $50.52M | $61.46M | $67.76M | $80.45M | $87.55M |
| Operating income | $-23.46M | $-26.74M | $-22.93M | $-40.94M | $-50.59M | $-41.34M | $-34.50M | $-27.87M |
| Operating margin | -114.8% | -108.9% | -50.3% | -75.1% | -132.4% | -84.2% | -48.4% | -31.5% |
| EBITDA | $-21.51M | $-24.93M | $-20.84M | $-35.47M | $-51.53M | $-37.10M | $-29.22M | $-21.88M |
| EBITDA margin | -105.3% | -101.5% | -45.8% | -65.1% | -134.9% | -75.6% | -41.0% | -24.7% |
| EBIT | $-23.25M | $-27.72M | $-23.75M | $-38.65M | $-57.38M | $-42.61M | $-34.67M | $-27.55M |
| Interest expense | $2.92M | $3.01M | $7.60M | $4.51M | $8.07M | $9.54M | $8.26M | $7.72M |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-26.17M | $-30.73M | $-31.35M | $-43.16M | $-65.45M | $-52.15M | $-42.93M | $-35.27M |
| Net income growth (YoY) | — | -17.4% | -2.0% | -37.7% | -51.6% | +20.3% | +17.7% | +17.9% |
| Profit margin | -128.1% | -125.1% | -68.8% | -79.2% | -171.3% | -106.2% | -60.2% | -39.8% |